Abstract
Type 1 diabetes is a chronic disease characterized by progressive destruction of the pancreatic β cells, what leads to insulin deficiency and hyperglycemia. However, a significant secretory function may persist for long periods in a few patients, what is clinically evident through the detection of serum C peptide. This phenomenon might reduce the risk of chronic complications, severe hypoglycemias and allow easier metabolic control. It is possible that these advantages are caused, at least partially, by C peptide itself, acting directly in its target tissues. Copyright© ABE&M.
Author supplied keywords
Cite
CITATION STYLE
Rodacki, M., Milech, A., & De Oliveira, J. E. P. (2008, March). A secreção residual do peptídeo C faz diferença no tratamento do diabetes melito tipo 1? Arquivos Brasileiros de Endocrinologia e Metabologia. https://doi.org/10.1590/S0004-27302008000200020
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.